» Articles » PMID: 22876119

A Novel MYOC Heterozygous Mutation Identified in a Chinese Uygur Pedigree with Primary Open-angle Glaucoma

Overview
Journal Mol Vis
Date 2012 Aug 10
PMID 22876119
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To characterize the clinical features of a Chinese Uygur pedigree with primary open-angle glaucoma (POAG) and to identify mutations in two candidate genes, trabecular meshwork inducible glucocorticoid response (MYOC/TIGR) and human dioxin-inducible cytochrome P450 (CYP1B1).

Methods: Twenty one members from a Chinese Uygur family of four generations were included in the study. All participants underwent complete ophthalmologic examinations. Five were diagnosed as POAG, four as glaucoma suspects, and the rest were asymptomatic. Molecular genetic analysis was performed on all subjects included in the study. All exons of CYP1B1 and MYOC were amplified by polymerase chain reaction (PCR), sequenced and compared with a reference database. The variations detected were evaluated in available family members as well as 102 normal controls. Possible changes in structure and function of the protein induced by amino acid variance were predicted by bioinformatics analysis.

Results: Elevated intraocular pressure and late-stage glaucomatous cupping of the optic disc were found in five patients of this family. A novel heterozygous missense mutation c.1151 A>G in exon 3 of MYOC was found in all five patients diagnosed as POAG and four glaucoma suspects, but not in the rest of the family members and 102 normal controls. This mutation caused an amino acid substitution of aspartic acid to glycine at position 384 (p. D384G) of the MYOC protein. This substitution may cause structural and functional changes of the protein based on bioinformatics analysis. No mutations were found in CYP1B1.

Conclusions: Our study suggests that the novel mutation D384G of MYOC is likely responsible for the pathogenesis of POAG in this pedigree.

Citing Articles

Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?.

Belamkar A, Harris A, Oddone F, Verticchio Vercellin A, Fabczak-Kubicka A, Siesky B J Clin Med. 2022; 11(9).

PMID: 35566612 PMC: 9099679. DOI: 10.3390/jcm11092486.


Research progress on human genes involved in the pathogenesis of glaucoma (Review).

Wang H, Sun P, Chen Y, Jiang L, Wu H, Zhang W Mol Med Rep. 2018; 18(1):656-674.

PMID: 29845210 PMC: 6059695. DOI: 10.3892/mmr.2018.9071.


Haplotype analysis of association of the MYOC gene with primary angle-closure glaucoma in a Han Chinese population.

Jin X, Wang D, Qu L, Hou B, Gong Y, Xu W Genet Test Mol Biomarkers. 2014; 19(1):3-8.

PMID: 25268471 PMC: 4278174. DOI: 10.1089/gtmb.2014.0130.


The nerve growth factor signaling and its potential as therapeutic target for glaucoma.

Wang H, Wang R, Thrimawithana T, Little P, Xu J, Feng Z Biomed Res Int. 2014; 2014:759473.

PMID: 25250333 PMC: 4164261. DOI: 10.1155/2014/759473.

References
1.
Vincent A, Billingsley G, Buys Y, Levin A, Priston M, Trope G . Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am J Hum Genet. 2002; 70(2):448-60. PMC: 384919. DOI: 10.1086/338709. View

2.
Kanagavalli J, Krishnadas S, Pandaranayaka E, Krishnaswamy S, Sundaresan P . Evaluation and understanding of myocilin mutations in Indian primary open angle glaucoma patients. Mol Vis. 2003; 9:606-14. View

3.
Zhao X, Yang C, Tong Y, Zhang X, Xu L, Li Y . Identification a novel MYOC gene mutation in a Chinese family with juvenile-onset open angle glaucoma. Mol Vis. 2010; 16:1728-35. PMC: 2927375. View

4.
Tamm E, Russell P . The role of myocilin/TIGR in glaucoma: results of the Glaucoma Research Foundation catalyst meeting in Berkeley, California, March 2000. J Glaucoma. 2001; 10(4):329-39. DOI: 10.1097/00061198-200108000-00014. View

5.
Fan B, Leung D, Wang D, Gobeil S, Raymond V, Tam P . Novel myocilin mutation in a Chinese family with juvenile-onset open-angle glaucoma. Arch Ophthalmol. 2006; 124(1):102-6. DOI: 10.1001/archopht.124.1.102. View